• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素及类泛素蛋白对蛋白质的修饰。

Modification of proteins by ubiquitin and ubiquitin-like proteins.

作者信息

Kerscher Oliver, Felberbaum Rachael, Hochstrasser Mark

机构信息

Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520, USA.

出版信息

Annu Rev Cell Dev Biol. 2006;22:159-80. doi: 10.1146/annurev.cellbio.22.010605.093503.

DOI:10.1146/annurev.cellbio.22.010605.093503
PMID:16753028
Abstract

Following the discovery of protein modification by the small, highly conserved ubiquitin polypeptide, a number of distinct ubiquitin-like proteins (Ubls) have been found to function as protein modifiers as well. These Ubls, which include SUMO, ISG15, Nedd8, and Atg8, function as critical regulators of many cellular processes, including transcription, DNA repair, signal transduction, autophagy, and cell-cycle control. A growing body of data also implicates the dysregulation of Ubl-substrate modification and mutations in the Ubl-conjugation machinery in the etiology and progression of a number of human diseases. The primary aim of this review is to summarize the latest developments in our understanding of the different Ubl-protein modification systems, including the shared and unique features of these related pathways.

摘要

在发现小的、高度保守的泛素多肽可对蛋白质进行修饰之后,人们又发现了许多不同的类泛素蛋白(Ubls)也能作为蛋白质修饰剂发挥作用。这些Ubls包括SUMO、ISG15、Nedd8和Atg8,它们是许多细胞过程的关键调节因子,这些过程包括转录、DNA修复、信号转导、自噬和细胞周期控制。越来越多的数据还表明,Ubl-底物修饰的失调以及Ubl-缀合机制中的突变与多种人类疾病的病因和进展有关。本综述的主要目的是总结我们对不同Ubl-蛋白质修饰系统理解的最新进展,包括这些相关途径的共同特征和独特特征。

相似文献

1
Modification of proteins by ubiquitin and ubiquitin-like proteins.泛素及类泛素蛋白对蛋白质的修饰。
Annu Rev Cell Dev Biol. 2006;22:159-80. doi: 10.1146/annurev.cellbio.22.010605.093503.
2
Protein-protein interactions regulate Ubl conjugation.蛋白质-蛋白质相互作用调节泛素样蛋白缀合。
Curr Opin Struct Biol. 2007 Dec;17(6):665-73. doi: 10.1016/j.sbi.2007.09.001. Epub 2007 Oct 15.
3
Protein modification by SUMO.小泛素样修饰蛋白介导的蛋白质修饰
Annu Rev Biochem. 2004;73:355-82. doi: 10.1146/annurev.biochem.73.011303.074118.
4
Ubiquitin and Ubiquitin-like proteins in cardiac disease and protection.泛素及类泛素蛋白在心脏疾病与心脏保护中的作用
Curr Drug Targets. 2018;19(9):989-1002. doi: 10.2174/1389450117666151209114608.
5
Ubiquitin-Like Modifiers: Emerging Regulators of Protozoan Parasites.泛素样修饰物:原虫寄生虫的新兴调节因子。
Biomolecules. 2020 Oct 3;10(10):1403. doi: 10.3390/biom10101403.
6
Using mass spectrometry to identify ubiquitin and ubiquitin-like protein conjugation sites.利用质谱法鉴定泛素及类泛素蛋白的缀合位点。
Proteomics. 2009 Feb;9(4):922-34. doi: 10.1002/pmic.200800666.
7
Ubiquitin-like modifications in the DNA damage response.DNA损伤应答中的类泛素修饰
Mutat Res. 2017 Oct;803-805:56-75. doi: 10.1016/j.mrfmmm.2017.07.001. Epub 2017 Jul 11.
8
Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins.类泛素蛋白进行翻译后修饰的结构机制。
Annu Rev Biophys Biomol Struct. 2007;36:131-50. doi: 10.1146/annurev.biophys.36.040306.132820.
9
Ubiquitin-like Protein Conjugation: Structures, Chemistry, and Mechanism.泛素样蛋白缀合:结构、化学和机制。
Chem Rev. 2018 Feb 14;118(3):889-918. doi: 10.1021/acs.chemrev.6b00737. Epub 2017 Feb 24.
10
Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins.泛素和类泛素蛋白修饰的急性髓系白血病相关蛋白。
Int J Mol Sci. 2022 Jan 3;23(1):514. doi: 10.3390/ijms23010514.

引用本文的文献

1
Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications.癌症中的坏死性凋亡:来自表观遗传、转录后和翻译后修饰的见解
J Hematol Oncol. 2025 Jul 30;18(1):77. doi: 10.1186/s13045-025-01726-x.
2
Structural basis for a nucleoporin exportin complex between RanBP2, SUMO1-RanGAP1, the E2 Ubc9, Crm1 and the Ran GTPase.RanBP2、SUMO1-RanGAP1、E2泛素结合酶Ubc9、Crm1与Ran GTP酶之间核孔蛋白输出蛋白复合物的结构基础。
Nat Commun. 2025 Jul 11;16(1):6403. doi: 10.1038/s41467-025-61694-1.
3
Regulation of disease signaling by YOD1: potential implications for therapeutic strategies.
YOD1对疾病信号的调控:对治疗策略的潜在影响。
Cancer Cell Int. 2025 Jun 24;25(1):232. doi: 10.1186/s12935-025-03881-0.
4
Synthetic inhibition of the SUMO pathway by targeting the SAE1 component via TAK-981 compound impairs growth and chemosensitizes embryonal and alveolar rhabdomyosarcoma cell lines.通过TAK-981化合物靶向SAE1组分对SUMO途径进行合成抑制会损害胚胎性和肺泡性横纹肌肉瘤细胞系的生长并使其对化疗敏感。
Mol Cell Biochem. 2025 Jun 23. doi: 10.1007/s11010-025-05336-6.
5
Emerging roles for E3 ubiquitin ligases in neural development and disease.E3泛素连接酶在神经发育和疾病中的新作用。
Front Cell Dev Biol. 2025 May 27;13:1557653. doi: 10.3389/fcell.2025.1557653. eCollection 2025.
6
MIB2-Mediated SUZ12 Ubiquitination Regulates Clonal Proliferation in Patients With Paroxysmal Nocturnal Haemoglobinuria.MIB2介导的SUZ12泛素化调节阵发性夜间血红蛋白尿患者的克隆增殖。
J Cell Mol Med. 2025 Jun;29(11):e70597. doi: 10.1111/jcmm.70597.
7
The Lysine Deprotonation Mechanism in a Ubiquitin Conjugating Enzyme.泛素结合酶中的赖氨酸去质子化机制
J Phys Chem B. 2025 May 22;129(20):4962-4968. doi: 10.1021/acs.jpcb.5c01486. Epub 2025 May 12.
8
Targeting PD-1 post-translational modifications for improving cancer immunotherapy.靶向程序性死亡受体1(PD-1)的翻译后修饰以改善癌症免疫治疗
Cell Insight. 2025 Apr 10;4(3):100248. doi: 10.1016/j.cellin.2025.100248. eCollection 2025 Jun.
9
NEDD4 signaling: a new frontier in the diagnosis and treatment of breast and ovarian cancers.NEDD4信号传导:乳腺癌和卵巢癌诊断与治疗的新前沿。
Med Oncol. 2025 May 6;42(6):200. doi: 10.1007/s12032-025-02751-z.
10
UFC1 reveals the multifactorial and plastic nature of oxyanion holes in E2 conjugating enzymes.UFC1揭示了E2共轭酶中氧阴离子洞的多因素和可塑性本质。
Nat Commun. 2025 Apr 25;16(1):3912. doi: 10.1038/s41467-025-58826-y.